Dissolution Testing - R&D services

Dissolution Testing  -  R&D services
Product Description

For us dissolution testing is never a routine test but an essential tool in pharmaceutical formulation development to:

• evaluate the physicochemical properties of drug candidates to select the most appropriate solid form for further development (pre-formulation)
• compare prototype formulations (preclinical selection),
• elucidate drug release mechanism (diffusion, erosion, etc.)
• as an indicator of stability (e.g., temperature, humidity)
• as an indicator of the robustness of the manufacturing and
• assure safe release and reproducibility of the products to the market.

Dissolution testing is to be a discriminatory method that is sensitive to variables that impact the release rate and ideally is predictive of bio-performance.

Read more: https://www.avivia.nl/lab-capabilities/dissolution

Avivia BV

  • NL
  • 2017
    On CPHI since
  • 1 - 24
    Employees
Company types
Academic/Research
Consultancy
Contract Research Organisation (CRO)
Contract Service
Pharmaceutical company
Primary activities
Analytical Services
Contract Research Organisation
Laboratory Services
Pharmaceutical Company (generic finished products)
Pharmaceutical Company (innovator finished products)
Specifications
  • Selling Points
    Experienced Technicians
  • Supplied from
    Netherlands

Avivia BV

  • NL
  • 2017
    On CPHI since
  • 1 - 24
    Employees
Company types
Academic/Research
Consultancy
Contract Research Organisation (CRO)
Contract Service
Pharmaceutical company
Primary activities
Analytical Services
Contract Research Organisation
Laboratory Services
Pharmaceutical Company (generic finished products)
Pharmaceutical Company (innovator finished products)

More Products from Avivia BV (4)

  • Excipia       Experts in excipient analysis, characterization and deformulation / reverse engineering

    Product Excipia Experts in excipient analysis, characterization and deformulation / reverse engineering

    Excipients can have an important impact on the manufacturability and pharmaceutical performance of a formulation. It’s therefore important to identify and control functionality related characteristics (FRCs) of excipient materials in order to achieve safe, robust and stable products. Expe...
  • Pharmaceutical R&D Services

    Product Pharmaceutical R&D Services

    Having decades of hands-on experience on a wide range of (complex) technologies and a many different types of products, our Pharmaceutical experts are able to fully execute and/or support the development of any finished dosage form, formula or process, as well as the transfer and scale-up of a deve...
  • Analytical research & development

    Product Analytical research & development

    Our analytical experts know what it takes to bring a pharmaceutical product to the market, from discovery, feasibility to GMP. Having worked with more than 100 unique molecules and even more formulations, we may state that we have faced the most difficult CMC challenges that are involved.
    ...
  • Excipient Quality Testing and Selection Services

    Product Excipient Quality Testing and Selection Services

    Excipient testing, composition and variabilityExcipients are either natural / naturally derived or synthetic / semi-synthetic. In all cases the exipients are obtained through chemical processing of a raw material source that usually has an animal, vegetable or mineral origin.

    ...

Avivia BV resources (1)

  • Brochure Avivia Services

    Brochure Avivia independent pharmaceutical development services.
    Established in 2005, Avivia is a specialized pharmaceutical development company engaged in CRO service activities, drug repositioning, repurposing and reformulation. Over the past fifteen years, the company has built a solid reputation recognized for its R&D flexibility and ‘out-of-the-box’ approach towards complex and challenging analytical and pharmaceutical development projects. Today, we are the preferred partner for many big pharma, specialty pharma, generic drug companies, academic centra, and smaller drug development firms.